Ascent Industries Co.

AI-generated fair value estimate for this company.

Method: 10-year DCF on consolidated EBITDA less capex and cash taxes: starts near breakeven in year 1 (2025 segment specialty-chemicals EBITDA was $8.1M, a 10.8% margin, offset by roughly $8.7M of standalone corporate costs following the mid-2025 divestiture of the tubing business) and ramps to ~$8-9M consolidated EBITDA by year 10 as corporate overhead is rationalized and revenue grows ~3%/yr off a $74.9M FY2025 base; ~$2.5-3.0M annual capex; 0% cash taxes years 1-3 (NOL usage), 25% thereafter; 12% discount rate; 2% terminal growth; plus $57.6M net cash (company is now debt-free after paying down $33M); 9.01M shares outstanding.

Reasoning: Ascent just completed a strategic pivot to a pure-play specialty-chemicals company (divesting American Stainless Tubing for $16M in mid-2025) and management explicitly calls this an 'early-stage turnaround' with segment margins already improved (gross margin 23.0% vs 13.2% in 2024) but corporate costs still dragging consolidated results to slightly negative EBITDA, so a normalized-EBITDA DCF that separates proven segment profitability from shrinking-but-uncertain corporate overhead is more defensible than extrapolating volatile historical net income (-$26.6M in 2023, -$13.6M in 2024, +$0.9M in 2025).